Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Jikei Nateglinide and Arbs for Vascular Intervention Study

Trial Profile

Jikei Nateglinide and Arbs for Vascular Intervention Study

Phase of Trial: Phase III

Latest Information Update: 12 May 2016

At a glance

  • Drugs Telmisartan (Primary) ; Valsartan (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms J-NAVI
  • Most Recent Events

    • 10 Aug 2014 Status changed from recruiting to completed as reported by UMIN record.
    • 07 May 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top